作者: Paolo Fava , Pietro Quaglino , Maria Teresa Fierro , Mauro Novelli , Maria Grazia Bernengo
DOI: 10.1111/J.1529-8019.2010.01360.X
关键词: Drug eruption 、 Pharmacology 、 Non small cell 、 Cancer research 、 Tyrosine kinase 、 Medicine 、 Vandetanib 、 Sun protection 、 Side effect 、 Phototoxic reactions 、 Kinase insert domain receptor
摘要: Vandetanib is an inhibitor of the vascular endothelial growth factor receptor 2 tyrosine kinase and epidermal kinase, recently used in treatment different tumors. We describe a case photo-allergic reaction to vandetanib 80-year-old Caucasian woman affected by metastatic non-small cell lung cancer. Phototoxic reactions have been rarely reported literature. Dermatologists should be aware this cutaneous side effect patients counseled use adequate sun protection.